Cargando…

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis

Aim: The influence of serum urate on kidney disease is attracting attention, but the effects of uric acid (UA) on nephrosclerosis have not been elucidated. Methods: We reviewed data from 45 patients diagnosed with arterial/arteriolar nephrosclerosis. The renal outcomes of the arterial/arteriolar nep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Momoki, Kumiko, Kataoka, Hiroshi, Moriyama, Takahito, Mochizuki, Toshio, Nitta, Kosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453688/ https://www.ncbi.nlm.nih.gov/pubmed/27784849 http://dx.doi.org/10.5551/jat.37523

Ejemplares similares

Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis
por: Sumida, Keiichi, et al.
Publicado: (2016)

Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study
por: Liang, Shaoshan, et al.
Publicado: (2016)

Clinicopathological discordance in biopsy-proven nephrosclerosis: a nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR)
por: Sumida, Keiichi, et al.
Publicado: (2021)

Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race
por: Hughson, Michael D., et al.
Publicado: (2014)

Clinical Phenotypes and Long-term Prognosis in White Patients With Biopsy-Verified Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2019)

Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions
por: Nakayama, Yuki, et al.
Publicado: (2022)

Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients
por: González, Luz M., et al.
Publicado: (2023)

Investigation into the underlying molecular mechanisms of hypertensive nephrosclerosis using bioinformatics analyses
por: Liu, Tianlong, et al.
Publicado: (2018)

Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis
por: Bramlage, Carsten P, et al.
Publicado: (2010)

Effect of Intensive Blood Pressure Control on Cardiovascular Remodeling in Hypertensive Patients with Nephrosclerosis
por: Randall, Otelio, et al.
Publicado: (2013)

Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients
por: González, Luz María, et al.
Publicado: (2021)

Serum Potassium Predicts Time to Blood Pressure Response Among African-Americans with Hypertensive Nephrosclerosis
por: Bhalla, Meeta, et al.
Publicado: (2012)

Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy
por: Gutsol, Alex A., et al.
Publicado: (2022)

Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
por: González, Luz M., et al.
Publicado: (2022)

Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis
por: Fanelli, Camilla, et al.
Publicado: (2023)

Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin–angiotensin system inhibitors on its prognosis
por: Sugiura, Naoko, et al.
Publicado: (2021)

Comparison of 6 equations for estimating glomerular filtration rate in a Chinese benign hypertensive nephrosclerosis population
por: Ke, Guibao, et al.
Publicado: (2021)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis
por: Han, Lin, et al.
Publicado: (2015)

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2018)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation
por: Wang, Zheng, et al.
Publicado: (2023)

Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map
por: Abe, Masanori, et al.
Publicado: (2016)

Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
por: Nordbø, Ole Petter, et al.
Publicado: (2023)

A Case of Significant Improvement of Heart Failure With Reduced Ejection Fraction With a Small Dose of Candesartan in a Hemodialysis Patient With Hypertensive Heart Disease and Nephrosclerosis
por: Harada, Haruhito, et al.
Publicado: (2023)

Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design
por: Nakamoto, Hidetomo, et al.
Publicado: (2014)

Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review
por: Sawada, Anri, et al.
Publicado: (2018)

Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining
por: Sato, Masayo, et al.
Publicado: (2021)

Glomerulopathy with Homozygous Apolipoprotein E2: A Report of Three Cases and Review of the Literature
por: Kawanishi, Kunio, et al.
Publicado: (2013)

Sex Differences in Time-Series Changes in Pseudo-R(2) Values Regarding Hyperuricemia in Relation to the Kidney Prognosis
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease
por: Manabe, Shun, et al.
Publicado: (2021)

Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan
por: Moriyama, Takahito, et al.
Publicado: (2014)

Retinal arteriolar parameters as a surrogate marker of intracranial vascular pathology
por: Abdelhak, Ahmed, et al.
Publicado: (2022)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016)

Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment
por: Iwabuchi, Yuko, et al.
Publicado: (2014)

A case of Lemierre syndrome combined with a suspected systemic lupus erythematosus flare
por: Fujii, Teruhiro, et al.
Publicado: (2019)

A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy
por: Itami, Shusaku, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eo51p318crhin4cgp1c8jms0u1